4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-007722
Chief Financial Officer sold 52,500 shares at $0.84 ($44,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2023-03-10 | Sale | −52,500 | $0.84 | $44,100 | 93,696 | D |
| Open-market sales · 52,500 sh · avg $0.84 · $44,100 | |||||||
Loading xslF345X03/wf-form4_167874064200077.xml…